Advertisement

Index by Author

November 1992; 41 (11)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Agius, L

    • Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes November 1992 41:1400-1408; doi:10.2337/diabetes.41.11.1400

  2. Ahmed, S

    • Phosphoribosyl pyrophosphate formation in the rat adrenal gland in relation to adrenal growth in experimental diabetes. Diabetes November 1992 41:1429-1435; doi:10.2337/diabetes.41.11.1429

  3. Alberti, K G

    • Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes November 1992 41:1400-1408; doi:10.2337/diabetes.41.11.1400

  4. Alford, F P

    • Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs. Diabetes November 1992 41:1446-1452; doi:10.2337/diabetes.41.11.1446

B

  1. Barrow, B

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  2. Bell, G I

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

  3. Best, J D

    • Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs. Diabetes November 1992 41:1446-1452; doi:10.2337/diabetes.41.11.1446

  4. Bouillon, R

    • 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes November 1992 41:1491-1495; doi:10.2337/diabetes.41.11.1491

  5. Bown, E

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  6. Buse, J B

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

C

  1. Catalano, C

    • Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes November 1992 41:1400-1408; doi:10.2337/diabetes.41.11.1400

  2. Chiu, K C

    • Glucokinase and NIDDM. A candidate gene that paid off. Diabetes November 1992 41:1367-1372; doi:10.2337/diabetes.41.11.1367

  3. Christopher, M J

    • Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs. Diabetes November 1992 41:1446-1452; doi:10.2337/diabetes.41.11.1446

  4. Christopher, P

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  5. Cook, J T

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  6. Cookson, W O

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

D

  1. Daniels, B S

    • Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model. Diabetes November 1992 41:1415-1421; doi:10.2337/diabetes.41.11.1415

  2. De Vries, R R

    • Beta-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient. A putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes November 1992 41:1380-1384; doi:10.2337/diabetes.41.11.1380

E

  1. Eschwege, E

    • Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes November 1992 41:1385-1389; doi:10.2337/diabetes.41.11.1385

F

  1. Farrace, S

    • Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats. Diabetes November 1992 41:1453-1463; doi:10.2337/diabetes.41.11.1453

  2. Fontbonne, A

    • Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes November 1992 41:1385-1389; doi:10.2337/diabetes.41.11.1385

  3. Fulcher, G R

    • Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes November 1992 41:1400-1408; doi:10.2337/diabetes.41.11.1400

G

  1. Greenbaum, A L

    • Phosphoribosyl pyrophosphate formation in the rat adrenal gland in relation to adrenal growth in experimental diabetes. Diabetes November 1992 41:1429-1435; doi:10.2337/diabetes.41.11.1429

H

  1. Hattersley, A T

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  2. Hauser, E B

    • Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model. Diabetes November 1992 41:1415-1421; doi:10.2337/diabetes.41.11.1415

  3. Hirai, S

    • Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol. Diabetes November 1992 41:1373-1379; doi:10.2337/diabetes.41.11.1373

  4. Hirashima, T

    • Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes November 1992 41:1422-1428; doi:10.2337/diabetes.41.11.1422

K

  1. Kallan, A A

    • Beta-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient. A putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes November 1992 41:1380-1384; doi:10.2337/diabetes.41.11.1380

  2. Kanatsuka, A

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  3. Karam, J H

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

  4. Kawano, K

    • Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes November 1992 41:1422-1428; doi:10.2337/diabetes.41.11.1422

  5. Kunjara, S

    • Phosphoribosyl pyrophosphate formation in the rat adrenal gland in relation to adrenal growth in experimental diabetes. Diabetes November 1992 41:1429-1435; doi:10.2337/diabetes.41.11.1429

  6. Kurosumi, M

    • Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes November 1992 41:1422-1428; doi:10.2337/diabetes.41.11.1422

L

  1. Laureys, J

    • 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes November 1992 41:1491-1495; doi:10.2337/diabetes.41.11.1491

  2. Lay, T P

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

M

  1. Makino, H

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  2. Martin, I K

    • Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs. Diabetes November 1992 41:1446-1452; doi:10.2337/diabetes.41.11.1446

  3. Mathieu, C

    • 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes November 1992 41:1491-1495; doi:10.2337/diabetes.41.11.1491

  4. McLean, P

    • Phosphoribosyl pyrophosphate formation in the rat adrenal gland in relation to adrenal growth in experimental diabetes. Diabetes November 1992 41:1429-1435; doi:10.2337/diabetes.41.11.1429

  5. Miyazaki, J

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  6. Mori, S

    • Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes November 1992 41:1422-1428; doi:10.2337/diabetes.41.11.1422

N

  1. Natori, T

    • Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes November 1992 41:1422-1428; doi:10.2337/diabetes.41.11.1422

  2. Neal, A R

    • G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes November 1992 41:1390-1399; doi:10.2337/diabetes.41.11.1390

O

  1. Ohsawa, H

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  2. Olson, A L

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

P

  1. Papoz, L

    • Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes November 1992 41:1385-1389; doi:10.2337/diabetes.41.11.1385

  2. Patel, P

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  3. Permutt, M A

    • Glucokinase and NIDDM. A candidate gene that paid off. Diabetes November 1992 41:1367-1372; doi:10.2337/diabetes.41.11.1367
    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  4. Pessin, J E

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

R

  1. Robertson, R P

    • G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes November 1992 41:1390-1399; doi:10.2337/diabetes.41.11.1390

  2. Roep, B O

    • Beta-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient. A putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes November 1992 41:1380-1384; doi:10.2337/diabetes.41.11.1380

  3. Roger, M

    • Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes November 1992 41:1385-1389; doi:10.2337/diabetes.41.11.1385

  4. Rossetti, L

    • Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats. Diabetes November 1992 41:1453-1463; doi:10.2337/diabetes.41.11.1453

S

  1. Saint-Paul, M

    • Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes November 1992 41:1385-1389; doi:10.2337/diabetes.41.11.1385

  2. Saitoh, T

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  3. Saitoh, Y

    • Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes November 1992 41:1422-1428; doi:10.2337/diabetes.41.11.1422

  4. Schrier, R W

    • Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes November 1992 41:1464-1472; doi:10.2337/diabetes.41.11.1464

  5. Seaquist, E R

    • G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes November 1992 41:1390-1399; doi:10.2337/diabetes.41.11.1390

  6. Seino, S

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

  7. Seo, T S

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

  8. Shaw, J A

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

  9. Shoger, K D

    • G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes November 1992 41:1390-1399; doi:10.2337/diabetes.41.11.1390

  10. Simon, D

    • Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes November 1992 41:1385-1389; doi:10.2337/diabetes.41.11.1385

  11. Sleeman, M W

    • Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs. Diabetes November 1992 41:1446-1452; doi:10.2337/diabetes.41.11.1446

  12. Sobis, H

    • 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes November 1992 41:1491-1495; doi:10.2337/diabetes.41.11.1491

  13. Sochor, M

    • Phosphoribosyl pyrophosphate formation in the rat adrenal gland in relation to adrenal growth in experimental diabetes. Diabetes November 1992 41:1429-1435; doi:10.2337/diabetes.41.11.1429

  14. Suzuki, S

    • Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol. Diabetes November 1992 41:1373-1379; doi:10.2337/diabetes.41.11.1373

T

  1. Taneda, Y

    • Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol. Diabetes November 1992 41:1373-1379; doi:10.2337/diabetes.41.11.1373

  2. Tanizawa, Y

    • Glucokinase and NIDDM. A candidate gene that paid off. Diabetes November 1992 41:1367-1372; doi:10.2337/diabetes.41.11.1367

  3. Taylor, S I

    • Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes November 1992 41:1473-1490; doi:10.2337/diabetes.41.11.1473

  4. Tokuyama, Y

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  5. Toyota, T

    • Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol. Diabetes November 1992 41:1373-1379; doi:10.2337/diabetes.41.11.1373

  6. Turner, R C

    • Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes November 1992 41:1496-1500; doi:10.2337/diabetes.41.11.1496

V

  1. Vandeputte, M

    • 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes November 1992 41:1491-1495; doi:10.2337/diabetes.41.11.1491

W

  1. Waer, M

    • 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes November 1992 41:1491-1495; doi:10.2337/diabetes.41.11.1491

  2. Walker, M

    • Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes November 1992 41:1400-1408; doi:10.2337/diabetes.41.11.1400

  3. Walseth, T F

    • G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes November 1992 41:1390-1399; doi:10.2337/diabetes.41.11.1390

  4. Ward, G M

    • Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs. Diabetes November 1992 41:1446-1452; doi:10.2337/diabetes.41.11.1446

  5. Williams, B

    • Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes November 1992 41:1464-1472; doi:10.2337/diabetes.41.11.1464

Y

  1. Yamaguchi, T

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  2. Yamamoto-Honda, R

    • Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol. Diabetes November 1992 41:1373-1379; doi:10.2337/diabetes.41.11.1373

  3. Yamamura, K

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

  4. Yasuda, K

    • Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation. Diabetes November 1992 41:1436-1445; doi:10.2337/diabetes.41.11.1436

  5. Yoshida, S

    • Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes November 1992 41:1409-1414; doi:10.2337/diabetes.41.11.1409

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement